Loss-of-function experiments showed that silencing SAPCD2 inhibited the proliferation and increased the apoptosis of fibrosarcoma cells in vitro, and repressed the lung metastasis of fibrosarcoma cells in vivo. The gene discussed is SAPCD2; the disease is fibrosarcoma.